4basebio Company Description

4basebio PLC engages in the research, development, manufacturing, and commercialization of synthetic DNA and RNA products, and targeted non-viral vector solutions in the United States, Europe, and internationally.

The company offers AVV and Lentivirus manufacturing services for use in gene therapies and vaccines. It also offers access to its targeted non-viral delivery platform, Hermes.

The company was formerly known as 4basebio UK Societas and changed its name to 4basebio PLC in July 2021.

4basebio PLC was founded in 2008 and is based in Cambridge, the United Kingdom.

4basebio PLC

Country	United Kingdom
Founded	2008
Industry	Biotechnology
Sector	Healthcare
Employees	84
CEO	Heikki Lanckriet

Contact Details

Address: 25 Norman Way Cambridge, CB24 5QE United Kingdom
Phone	44 1223 967 943
Website	4basebio.com

Stock Details

Ticker Symbol	4BB
Exchange	London Stock Exchange AIM
Fiscal Year	January - December
Reporting Currency	GBP
ISIN Number	GB00BMCLYF79
SIC Code	2836

Key Executives

Name	Position
Heikki Lanckriet	Chief Executive Officer
David Roth	Chief Financial Officer